Cytotoxic analogues of 2,6-bis(arylidene)cyclohexanones

European Journal of Medicinal Chemistry

Volumn 38, Issue 2, 2003, Pages 169-177

  Dimmock, Jonathan R ^a   Padmanilayam, Maniyan P ^a   Zello, Gordon A ^a   Nienaber, Kurt H ^a   Allen, Theresa M ^b   Santos, Cheryl L ^b   De Clercq, Erik ^c   Balzarini, Jan ^c   Manavathu, Elias K ^d   Stables, James P ^e  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Bioscreens; Cytotoxicity; Structure activity relationships; , Unsaturated ketones

Indexed keywords

CYCLOHEXANONE DERIVATIVE; CYTOTOXIC AGENT; FLUOROURACIL; FUNCTIONAL GROUP; KETONE DERIVATIVE; SARCOLYSIN;

ALKYLATION; ANIMAL CELL; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; COLON CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TOLERABILITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION; T CELL LEUKEMIA;

EID: 0037293779     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(02)01444-7     Document Type: Article

References (36)

1. Dimmock J.R., Arora V.K., Wonko S.L., Hamon N.W., Quail J.W., Jia Z., Warrington R.C., Fang W.D., Lee J.S. Drug Des. Deliv. 6:1990;183-194.
2. Craig P.N. J. Med. Chem. 14:1971;680-684.
3. Pandeya S.N., Dimmock J.R. An Introduction to Drug Design. 1997;94 New Age International (P) Ltd. Publishers, New Delhi.
4. MacroModel, version 4.5, Department of Chemistry, Columbia University, NY, August 1994.
5. Hansch C., Leo A.J. Substituent Constants for Correlation Analysis in Chemistry and Biology. 1979;52-53 Wiley, New York.
6. Dimmock J.R., Taylor W.G. J. Pharm. Sci. 64:1975;241-249.
7. Dimmock J.R., Nyathi C.B., Smith P.J. J. Pharm. Sci. 67:1978;1543-1546.
8. Rousseaux C.G., Townsend H.G., Phillips O.A., Dimmock J.R. Fundam. Appl. Toxicol. 14:1990;318-326.
9. Dimmock J.R., Kumar P., Nazarali A.J., Motaganahalli N.L., Kowalchuk T.P., Beazely M.A., Quail J.W., Oloo E.O., Allen T.M., Szydlowski J., De Clercq E., Balzarini J. Eur. J. Med. Chem. 35:2000;967-977.
10. Dimmock J.R., Padmanilayam M.P., Puthucode R.N., Nazarali A.J., Motaganahalli N.L., Zello G.A., Quail J.W., Oloo E.O., Kraatz H.-B., Prisciak J.S., Allen T.M., Santos C.L., Balzarini J., De Clercq E., Manavathu E.K. J. Med. Chem. 44:2001;586-593.
11. Dimmock J.R., Kandepu N.M., Nazarali A.J., Kowalchuk T.P., Motaganahalli N., Quail J.W., Mykytiuk P.A., Audette G.F., Prasad L., Perjési P., Allen T.M., Santos C.L., Szydlowski J., De Clercq E., Balzarini J. J. Med. Chem. 42:1999;1358-1366.
12. Dimmock J.R., Jha A., Kumar P., Zello G.A., Quail J.W., Oloo E.O., Oucharek J.J., Pasha M.K., Seitz D., Sharma R.K., Allen T.M., Santos C.L., Manavathu E.K., De Clercq E., Balzarini J., Stables J.P. Eur. J. Med. Chem. 37:2002;35-44.
13. Boyd M.R., Paull K.D. Drug Dev. Res. 34:1995;91-109.
14. Dimmock J.R., Phillips O.A., Wonko S.L., Hickie R.A., Tuer R.G., Ambrose S.J., Reid R.S., Mutus B., Talpas C.J. Eur. J. Med. Chem. 24:1989;217-226.
15. Dimmock J.R., Vashishtha S.C., Patil S.A., Udupa N., Dinesh S.B., Devi P.U., Kamath R. Pharmazie. 53:1998;702-706.
16. Foye W.O., Sengupta S.K. Foye W.O., Lemke T.L., Williams D.A. Principles of Medicinal Chemistry. 4th ed. 1995;833 Williams and Wilkins, Baltimore, MD.
17. Greenspan E.M., Bruckner H.W. Greenspan E.M. Clinical Cancer Chemotherapy. 1975;37 Raven Press, New York.
18. Dimmock J.R., Qureshi A.M., Noble L.M., Smith P.J., Baker H.A. J. Pharm. Sci. 65:1976;38-43.
19. Dimmock J.R., Hamon N.W., Hindmarsh K.W., Mills D.G., Negrave L.E., Rank G.H., Robertson A.J. J. Pharm. Sci. 65:1976;482-488.
20. Manavathu E.K., Dimmock J.R., Vashishtha S.C., Chandrasekar P.H. J. Antimicrob. Chemother. 47:2001;491-494.
21. Duncan K.M., Ogawa G., Clibon U. Herfindal E.T., Gourley D.R. Textbook of Therapeutics. 7th ed. 2000;1699-1710 Lippincott Williams and Wilkins, Philadelphia, PA.
22. Dimmock J.R., Jonnalagadda S.S., Phillips O.A., Erciyas E., Shyam K., Semple H.A. J. Pharm. Sci. 81:1992;436-440.
23. Dunham M.S., Miya T.A. J. Am. Pharm. Assoc. Sci. Ed. 46:1957;208-209.
24. Smith P.J., Dimmock J.R., Turner W.A. Can. J. Chem. 51:1973;1458-1470.
25. Engel P.S., Kitamura A., Keys D.E. J. Org. Chem. 52:1987;5015-5021.
26. H. Frey, Synthesis (1992) 387-90.
27. Denney D.B., Ross S.T. J. Org. Chem. 27:1962;998-1000.
28. Srikishna A., Kumar P.P., Viswajanani R. Tetrahedron Lett. 37:1996;1683-1686.
29. Haslanger M., Lawton R.G. Synth. Commun. 4:1974;155-159.
30. J.B. Aldersley, G.N. Burkhardt, A.E. Gillam, N.C. Hindley, J. Chem. Soc. (1940) 10-6.
31. Hansch C., Leo A.J. Substituted Constants for Correlation Analysis in Chemistry and Biology. 1979;47, 49 Wiley, New York.
32. Statistical Package for Social Sciences, SPSS for Windows, Standard Version, Release 10.0.5, SPSS Inc., Chicago, IL, 1999.
33. Phillips O.A., Nelson L.A., Knaus E.E., Allen T.M., Fathi-Afshar R. Drug Des. Deliv. 4:1989;121-127.
34. Balzarini J., De Clercq E., Mertes M.P., Shugar D., Torrence P.F. Biochem. Pharmacol. 31:1982;3673-3682.
35. National Committee for Clinical Laboratory Standards, Publications M38-P and M27-A, NCCLS, Wayne, PA, 1997.
36. Stables J.P., Kupferberg H.J. Vanzini G.A., Tanganelli P., Avoli M. Molecular and Cellular Targets for Antiepileptic Drugs. 1997;191-198 John Libbey and Company Ltd, London.